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Foreword
Iodine is an essential constituent of the thyroid hormones that
are vital for optimal physical growth and for the normal
development of the human brain during gestation and the
first few years of life. From conception to at least 6months of
age, the iodine status of a breast-fed child is dependent on the
iodine status of the child’s mother. The consequences
of iodine deficiency for foetal and infant development range
from stillbirth, premature delivery, neonatal hypothyroidism
andendemic cretinism tomoderate ormildbrain damage that
impairs the intellectual and motor development of children.
If not prevented, these changes are mostly irreversible.
The iodine in the human diet comes mainly from eating
plants grown in soils that contain the mineral or from
consuming herbivorous animals. The need for iodine from
the diet may be difficult to meet in an environment in
which the soil and water contain little iodine as a result of
glaciation, erosion or leaching by heavy rainfall. As this
happens in many parts of the world, it explains why the
diets of people of both the industrialised and non-
industrialised world are commonly deficient in iodine
unless specific measures are taken to add iodine to food.
In 1990, the World Health Assembly urged all Member
States to eliminate iodine deficiency disorders1 and
endorsed salt iodisation as the main strategy to reach this
goal. To achieve this goal, the WHO set a target for more
than 90% of households to use adequately iodised salt2.
Data from recent surveys indicate that 67% of households
worldwide are now consuming iodised table salt3.
The effectiveness of salt iodisation as a mean to reduce
iodine deficiency disorders is strongly related to commit-
ment of governments, the enactment of legislation to add
iodine to all salt used for human and animal consumption,
and public health education to incite people to buy and use
iodised salt. Although 67% of households may now be
consuming iodised table salt, recent surveys of urinary
iodine concentrations have indicated that the iodine intake
is still insufficient in 54 countries, either because iodised
table salt is not available or because it is poorly distributed4
(WHO, 2004). Many other countries have pockets where
iodised salt is not used. In these countries and areas, the
groups most vulnerable to the effects of iodine deficiency
are pregnant women and young children.
From the earliest stages of gestation, thyroid hormones
produced by the mother pass across the placenta to
stimulate cell division and differentiation in the foetal
brain. Pregnancy is associated with a rapid increase in
thyroid hormone production. This means that the mother’s
need for iodine increases during pregnancy because she is
making additional thyroid hormones both for herself and
for her foetus; because she is providing the future child
with a store of iodine for the first months of life and
because her daily losses of iodine in the urine are believed
to be greater than normal. A mother’s greater need for
iodine continues during lactation because her breast milk
should be the sole source of her infant’s nutritional needs,
including iodine, for the first 6months of life5.
The infant also needs a supply of iodine throughout the
first few years of life; particularly after breast-feeding has
stopped. This is another crucial period for brain develop-
ment, and the supply of iodine has to be sustained
throughout the period when complementary foods are
given and until the child begins to eat the normal family diet.
Thus, there are three crucial periods to ensure an
adequate iodine intake during early child development:
pregnancy, especially during the first half; during the first
6months of life; and throughout the period of comp-
lementary feeding. International concern for iodine
nutrition during these critical periods of early life led the
WHO to convene a Technical Consultation to examine the
iodine status and iodine needs of three key groups:
pregnant women, lactating women and children less than
2 years of age. The objectives of the meeting were: (1) to
review the functional consequences of iodine deficiency
for pregnant women and for child development, and
review its public health significance; (2) to review the
current requirements for iodine by pregnant and lactating
women and children less than 2 years of age; (3) to review
the current indicators for an adequate iodine nutrition
status in these groups and (4) to review current strategies
to eliminate iodine deficiency disorders in these groups.
The WHO commissioned five review papers on the
following issues: (1) iodine requirements during preg-
nancy, lactation and the neonatal period, and indicators of
optimal iodine nutrition; (2) the importance of iodine
nutrition during pregnancy; (3) iodine deficiency and
brain development; (4) the prevalence of iodine
deficiency among women of reproductive age and (5)
the impact of salt iodisation or iodine supplementation on
iodine status during pregnancy, lactation and infancy.
These papers were presented during the consultation and
discussed in detail. After the presentations based on these
papers, the meeting broke into two working groups to
make recommendations to the WHO and its Member
States on iodine requirements, on assessing iodine status
and on measures to prevent and control iodine deficiency
in the target groups. These papers, the summary of the
discussion and the recommendations are presented in this
issue of the Journal of Public Health Nutrition.
The main conclusion of this consultation is to increase
iodine intake through supplementation to pregnant
women and lactating women, and through breast-feeding
and fortified complementary foods to infants and young
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children, where a population’s coverage with iodised salt
is not sufficient to ensure an adequate iodine intake to
these groups at risk. Iodine supplements come as a
complement to iodised salt and not as an alternative.
It is hoped that the implementation of the recommen-
dations of this consultation will contribute to reach the
goal of elimination of iodine deficiency and therefore to
the achievement of the Millennium Development Goals.
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